ArticleInternational journal of antimicrobial agents2020
COVID-19 Therapeutic and Prevention.
Article in International journal of antimicrobial agents, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Targeting SARS-CoV-2 main protease by teicoplanin: A mechanistic insight by docking, MM/GBSA and molecular dynamics simulation.Journal of molecular structure · 2021Article
- Elucidation of Teicoplanin Interactions with Drug Targets Related to COVID-19.Antibiotics (Basel, Switzerland) · 2021Article
- 8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load.Scientific reports · 2021Article
- A Review of CurrentFrontiers in oncology · 2021Review
- Adaptation of a Russian population to SARS-CoV-2: Asymptomatic course, comorbidities, mortality, and other respiratory viruses - A reply to Fear versus Data.International journal of antimicrobial agents · 2020Article
- Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options.Molecular therapy. Methods & clinical development · 2020Review
- Gut Microbiota Status in COVID-19: An Unrecognized Player?Frontiers in cellular and infection microbiology · 2020Review
- COVID-19 Drug Treatment in China.Current pharmacology reports · 2020Review
- COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!Journal of clinical and experimental hepatologyReview
- Immunity, Sex Hormones, and Environmental Factors as Determinants of COVID-19 Disparity in Women.Frontiers in immunologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.